ABG 200

Pill imprint ABG 200 has been identified as Morphine sulphate extended-release 200 mg.

Morphine is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.

Morphine 200 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.

Morphine sulphate extended-release Images

Imprint:
ABG
200
Strength:
200 mg
Color:
Green
Shape:
Rectangle
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3515
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42858-0805 Rhodes Pharmaceuticals
00591-3744 Watson Pharmaceuticals, Inc.

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Morphine sulphate extended-release 200 mg ABG 200
Morphine sulphate extended-release 200 mg ABG 200
Advertisement

Morphine Sulphate Extended-Release is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web3)